MYC and Neoplasm of the liver: In krasV12-expressing liver tumours, progressively increasing activation of MAPK and Wnt/β-catenin signalling pathways was observed from benign to malignant tumours [34,56]; inhibition of Wnt-signalling also reduced oncogenic liver size in Myc fish [67].